Cancer care support for patients with leukemia
Part of Blood & lymphatic, Cancer clinical trials.
This trial studies how screening for social needs (like housing, food, or transportation) and offering early help can improve care for adults with leukemia. It is for patients newly referred to a leukemia clinic.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a new diagnosis of acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), or a high-risk myelodysplastic syndrome (MDS) or chronic myelomonocytic leukemia (CMML).
- If you have a lower-risk MDS or CMML, you may also qualify if you need at least 2 red blood cell transfusions every 28 days or will need to visit the leukemia clinic more than once a month.
- You can complete surveys in English or Spanish (or with an interpreter).
- You are able to give your own consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is beta-testing a new app designed to reduce healthcare disparities among people admitted to the hospital with suspected acute leukemia. Your feedback could help make the app more helpful for future patients.
This trial tests an emotion- and symptom-focused way of engaging with care for people who are newly diagnosed with acute leukemia and starting intensive “induction” treatment aimed at cure. It may help you feel better supported and better able to manage distressing symptoms during a critical early phase of treatment.
This study tests whether a formal support program can help people newly diagnosed with acute leukemia. If you're starting treatment at the Centre Henri Becquerel, this program may offer extra guidance and help improve your quality of life.
This study tests a program that adds extra aging-related support to standard care for older adults with acute myeloid leukemia (AML) starting a type of treatment called venetoclax-based therapy. The goal is to see if this extra support improves quality of life and well-being.
This study is testing whether a financial navigation program can help adults with newly diagnosed acute myeloid leukemia (AML) who are about to start or have just started intensive chemo. The goal is to see if providing money guidance reduces stress and improves their care.
This study tests an approach to help people with certain blood cancers and their main caregiver plan ahead and communicate more clearly about end-of-life care. It may help patients feel more supported and better prepared for difficult decisions.
Hear when a new Leukemia, Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.